Chrysin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis in rats.
10.19540/j.cnki.cjcmm.20221201.705
- Author:
Jin-Feng SHANG
1
;
Jia-Kang JIAO
1
;
Qian-Nan LI
1
;
Ying-Hui LU
1
;
Jing-Yi WANG
1
;
Ming-Xue YAN
1
;
Yin-Lian WEN
1
;
Gui-Jin-Feng HUANG
1
;
Xiao-Lu ZHANG
1
;
Xin LIU
1
Author Information
1. School of Chinese Materia Medica,Beijing University of Chinese Medicine Beijing 100029,China.
- Publication Type:Journal Article
- Keywords:
animal experiments;
cerebral ischemia-reperfusion;
chrysin;
ferroptosis;
pharmacological mechanism
- MeSH:
Rats;
Male;
Animals;
Rats, Sprague-Dawley;
Ferroptosis;
Signal Transduction;
Brain Ischemia/metabolism*;
Cyclooxygenase 2/metabolism*;
RNA, Messenger;
Cerebral Infarction;
Reperfusion Injury/metabolism*;
Malondialdehyde;
Infarction, Middle Cerebral Artery
- From:
China Journal of Chinese Materia Medica
2023;48(6):1597-1605
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of this study is to investigate whether chrysin reduces cerebral ischemia-reperfusion injury(CIRI) by inhi-biting ferroptosis in rats. Male SD rats were randomly divided into a sham group, a model group, high-, medium-, and low-dose chrysin groups(200, 100, and 50 mg·kg~(-1)), and a positive drug group(Ginaton, 21.6 mg·kg~(-1)). The CIRI model was induced in rats by transient middle cerebral artery occlusion(tMCAO). The indexes were evaluated and the samples were taken 24 h after the operation. The neurological deficit score was used to detect neurological function. The 2,3,5-triphenyl tetrazolium chloride(TTC) staining was used to detect the cerebral infarction area. Hematoxylin-eosin(HE) staining and Nissl staining were used to observe the morphological structure of brain tissues. Prussian blue staining was used to observe the iron accumulation in the brain. Total iron, lipid pero-xide, and malondialdehyde in serum and brain tissues were detected by biochemical reagents. Real-time quantitative polymerase chain reaction(RT-qPCR), immunohistochemistry, and Western blot were used to detect mRNA and protein expression of solute carrier fa-mily 7 member 11(SLC7A11), transferrin receptor 1(TFR1), glutathione peroxidase 4(GPX4), acyl-CoA synthetase long chain family member 4(ACSL4), and prostaglandin-endoperoxide synthase 2(PTGS2) in brain tissues. Compared with the model group, the groups with drug intervention showed restored neurological function, decreased cerebral infarction rate, and alleviated pathological changes. The low-dose chrysin group was selected as the optimal dosing group. Compared with the model group, the chrysin groups showed reduced content of total iron, lipid peroxide, and malondialdehyde in brain tissues and serum, increased mRNA and protein expression levels of SLC7A11 and GPX4, and decreased mRNA and protein expression levels of TFR1, PTGS2, and ACSL4. Chrysin may regulate iron metabolism via regulating the related targets of ferroptosis and inhibit neuronal ferroptosis induced by CIRI.
